![]() ![]() Objective To determine the use of evidence-based cardiovascular preventive therapies in a broad US population with diabetes and ASCVD.ĭesign, Setting, and Participants This multicenter cohort study used health system–level aggregated data within the National Patient-Centered Clinical Research Network, including 12 health systems. Importance Based on contemporary estimates in the US, evidence-based therapies for cardiovascular risk reduction are generally underused among patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography. ![]()
0 Comments
Leave a Reply. |